Palisade Bio (PALI) Other Non-Current Liabilities (2012 - 2026)

Palisade Bio (PALI) has 15 years of Other Non-Current Liabilities data on file, last reported at $271000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 13450.0% year-over-year to $271000.0 in Q1 2026; TTM through Mar 2026 was $271000.0, a 13450.0% increase from a year earlier, with the FY2025 full-year figure at $266000.0, up 77.33% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $271000.0, up from $266000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for PALI reached as high as $1.7 million in Q1 2022 and fell as low as $2000.0 in Q2 2023.
• Historically, Other Non-Current Liabilities has averaged $223466.7 across 5 years, with a median of $75000.0 in 2025.
• Across the five-year window, Other Non-Current Liabilities plunged 99.57% in 2023 and jumped 13450.0% in 2026, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $84000.0 in 2022, then plunged by 97.62% to $2000.0 in 2023, then surged by 7400.0% to $150000.0 in 2024, then soared by 77.33% to $266000.0 in 2025, then climbed by 1.88% to $271000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $271000.0 in Q1 2026, $266000.0 in Q4 2025, and $75000.0 in Q2 2025.